Mega Genomics Limited is a China-based investment holding company principally engaged in genetic testing business, which concentrates on consumer grade genetic testing and cancer screening services. The main products and services of company operated by three segments: 1. The Consumer Genetic Testing Services segment provides testing for nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, pharmacogenetic testing and infectious disease testing; 2. The Cancer Screening Services segment provides Septin9 colorectal cancer screening test, Syndecan-2 (SDC2) colorectal cancer screening test and ring finger protein 180 (RNF180)/Septin9 gastric cancer screening test; 3. The Other Services segment provides genetic research and analysis services to third party research institutions. The company was established in 2021 and is headquartered in Beijing City, China, and operating a place of business in Hong Kong.
Headquarters
401 Health Work, North Garden Road, Haidian
Beijing; Beijing;
Contact Details: Purchase the Mega Genomics Limited report to view the information.
Website: http://www.megagenomics.cn
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service